Similar Papers

Paper Title
Journal
Date
Author
Targeting the tumor-stromal-immune cell axis.
Murali Gururajan ... Leland W.K Chung
Oncoscience | VOL. 2
Murali Gururajan, et. al.Murali Gururajan ... Leland W.K Chung
11 Aug 2015
Blocking CD47 promotes antitumour immunity through CD103+ dendritic cell–NK cell axis in murine hepatocellular carcinoma model
Shuai Wang ... Shusen Zheng
Journal of Hepatology | VOL. 77
Shuai Wang, et. al.Shuai Wang ... Shusen Zheng
01 Apr 2022
Abstract 2100: Dendritic cell-intrinsic PTPN22 negatively regulates anti-tumor immunity
Santiago Acero-Bedoya ... Emily F Higgs
Cancer Research | VOL. 82
Santiago Acero-Bedoya, et. al.Santiago Acero-Bedoya ... Emily F Higgs
15 Jun 2022
978 Dendritic cell-intrinsic PTPN22 negatively regulates anti-tumor immunity
Santiago Acero-Bedoya ... Emily Higgs
Journal for ImmunoTherapy of Cancer | VOL. 10
Santiago Acero-Bedoya, et. al.Santiago Acero-Bedoya ... Emily Higgs
01 Nov 2022
View more papers

More From: Cancer letters

Paper Title
Journal
Date
Author
FUT2-dependent fucosylation of LAMP1 promotes the apoptosis of colorectal cancer cells by regulating the autophagy-lysosomal pathway.
Zijun Guo ... Rong Lin
Cancer letters | VOL. 619
Zijun Guo, et. al.Zijun Guo ... Rong Lin
01 Jun 2025
Generating research hypotheses to overcome key challenges in the early diagnosis of colorectal cancer - Future application of AI.
Lan Yao ... Gang Wang
Cancer letters | VOL. 620
Lan Yao, et. al.Lan Yao ... Gang Wang
01 Jun 2025
Anticancer therapy-induced peripheral neuropathy in solid tumors: diagnosis, mechanisms, and treatment strategies.
Jiahong Jiang ... Liu Yang
Cancer letters | VOL. 620
Jiahong Jiang, et. al.Jiahong Jiang ... Liu Yang
01 Jun 2025
Glycosaminoglycan modification of NRP1 exon 4-skipping variant drives colorectal cancer metastasis via endosomal-exosomal trafficking.
Yiwei Gu ... Qing-Bai She
Cancer letters | VOL. 620
Yiwei Gu, et. al.Yiwei Gu ... Qing-Bai She
01 Jun 2025
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.